Orthofix Medical Inc. (OFIX) stock
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3051% below fair value
$6.94−0.24 (-3.34%)
Close on Nov 12, 2026Market cap $282.68MP/E –Yield –
Orthofix Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Orthofix Medical's ebitda for the twelve months ending Sep 30, 2026 was $32.49M. For fiscal 2025 it was -$4.11M. The highest annual figure on record is $93.17M in fiscal 2012.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.11M | – |
| FY2024 | Dec 31, 2024 | -$24.56M | – |
| FY2023 | Dec 31, 2023 | -$86.05M | -646.3% |
| FY2022 | Dec 31, 2022 | $15.75M | -26.0% |
| FY2021 | Dec 31, 2021 | $21.28M | -12.3% |
| FY2020 | Dec 31, 2020 | $24.28M | +310.5% |
| FY2019 | Dec 31, 2019 | $5.92M | -87.9% |
| FY2018 | Dec 31, 2018 | $48.75M | -20.0% |
| FY2017 | Dec 31, 2017 | $60.94M | +45.4% |
| FY2016 | Dec 31, 2016 | $41.91M | +38.9% |
| FY2015 | Dec 31, 2015 | $30.18M | -24.6% |
| FY2014 | Dec 31, 2014 | $40.01M | +244.1% |
| FY2013 | Dec 31, 2013 | $11.63M | -87.5% |
| FY2012 | Dec 31, 2012 | $93.17M | +212.7% |
| FY2011 | Dec 31, 2011 | $29.79M | -66.2% |
| FY2010 | Dec 31, 2010 | $88.07M | +2.1% |
| FY2009 | Dec 31, 2009 | $86.22M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $14.72M | – |
| Q2 FY2026 | Jun 30, 2026 | $5.14M | +492.1% |
| Q1 FY2026 | Mar 31, 2026 | -$943.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $13.57M | +200.5% |
| Q3 FY2025 | Sep 30, 2025 | -$4.11M | – |
| Q2 FY2025 | Jun 30, 2025 | $868.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.44M | – |
| Q4 FY2024 | Dec 31, 2024 | $4.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.73M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.87M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.48M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.35M | -736.7% |
| Q2 FY2023 | Jun 30, 2023 | -$23.31M | -277.2% |
| Q1 FY2023 | Mar 31, 2023 | -$47.04M | -1160.0% |
| Q4 FY2022 | Dec 31, 2022 | -$3.62M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.78M | -73.9% |
| Q2 FY2022 | Jun 30, 2022 | $13.15M | +11.2% |
| Q1 FY2022 | Mar 31, 2022 | $4.44M | -2.0% |
| Q4 FY2021 | Dec 31, 2021 | -$1.91M | -116.0% |
| Q3 FY2021 | Sep 30, 2021 | $6.84M | -48.2% |
| Q2 FY2021 | Jun 30, 2021 | $11.83M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.53M | -65.7% |
| Q4 FY2020 | Dec 31, 2020 | $11.95M | +12.6% |
| Q3 FY2020 | Sep 30, 2020 | $13.21M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.06M | -312.1% |
| Q1 FY2020 | Mar 31, 2020 | $13.18M | +930.6% |
| Q4 FY2019 | Dec 31, 2019 | $10.61M | -39.0% |
| Q3 FY2019 | Sep 30, 2019 | -$12.61M | -245.8% |
| Q2 FY2019 | Jun 30, 2019 | $6.63M | -36.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.28M | -89.5% |
| Q4 FY2018 | Dec 31, 2018 | $17.40M | -22.9% |
| Q3 FY2018 | Sep 30, 2018 | $8.65M | -38.3% |
| Q2 FY2018 | Jun 30, 2018 | $10.47M | -21.7% |
| Q1 FY2018 | Mar 31, 2018 | $12.24M | +11.3% |
| Q4 FY2017 | Dec 31, 2017 | $22.56M | +76.6% |
| Q3 FY2017 | Sep 30, 2017 | $14.01M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.37M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.99M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.77M | – |
See a number that looks wrong?